Open access · Peer reviewed · Scopus journal
Gastric acid suppressing drugs and NSAIDs
- 1*
- 1October 2012 NEWS HbA1c levels, which are currently measured in percentage units, will be measured in millimoles per mole (mmol/ mol) by all countries from later part of 2012 onwards,[1] following a recommendation by the International Federation of Clinical Chemistry. An online HbA1c converter is also available.[2] One blogger has come out with an easier way to convert the percentage to mmol/mol as follows, though it can be applied only to decimal free figures: 6% is 42 mmol/mol 6-2 is 4 and then 4-2 is 2, hence 42 7% is 53 mmol/mol 7-2 is 5 and then 5-2 is 3, hence 53 8% is 64 mmol/mol 8-2 is 6 and then 6-2 is 4, hence 64 9% is 75 mmol/mol 9-2 is 7 and then 7-2 is 5, hence 75 Or remember 6% = 42 mmol/mol and then on add 11 for each % increase (again only to decimal-free figures). G Sivagnanam Department of Pharmacology, Indira Gandhi Medical College and [Downloaded free from http://www.jpharmacol.com on Wednesday, October 13, 2021, IP: 157.45.222.78].
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: G Sivagnanam
October 2012 NEWS HbA1c levels, which are currently measured in percentage units, will be measured in millimoles per mole (mmol/ mol) by all countries from later part of 2012 onwards,[1] following a recommendation by the International Federation of Clinical Chemistry. An online HbA1c converter is also available.[2] One blogger has come out with an easier way to convert the percentage to mmol/mol as follows, though it can be applied only to decimal free figures: 6% is 42 mmol/mol 6-2 is 4 and then 4-2 is 2, hence 42 7% is 53 mmol/mol 7-2 is 5 and then 5-2 is 3, hence 53 8% is 64 mmol/mol 8-2 is 6 and then 6-2 is 4, hence 64 9% is 75 mmol/mol 9-2 is 7 and then 7-2 is 5, hence 75 Or remember 6% = 42 mmol/mol and then on add 11 for each % increase (again only to decimal-free figures). G Sivagnanam Department of Pharmacology, Indira Gandhi Medical College and [Downloaded free from http://www.jpharmacol.com on Wednesday, October 13, 2021, IP: 157.45.222.78].
Copyright: © 2012 The Author(s). This is an open access article.
Published: Jan 1, 2012
- DOI
- Not available yet
Abstract
Based on several case reports implicating diclofenac, a population-based case-control study undertaken in UK, found that among all the NSAIDs, diclofenac usage has been associated with a modest increase in the risk of C. difficile associated disease (CDAD). It has been suggested that NSAIDs other than diclofenac may be preferred in patients at risk,[2] which includes acid peptic disorders, GI surgery, diabetes mellitus, hepato renal failure, etc . Whether diclofenac is more effective than other NSAIDs in breaching the GI protective barrier or is a more effective inhibitor of neutrophilic activation or hitherto unknown mechanism is involved in the said association is yet to be established.
Keywords
Subject
Recommended articles
- New(s): Are these terms new(s)!?
G. Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Antibiotics with a curse of cardiovascular risk
G Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Acetaminophen associated with risk of hearing loss: A safety alert
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- Majority general practitioners prescribe “Impure Placebo” drugs
· Journal of Pharmacology and Pharmacotherapeutics
- A new drug belonging to a novel class of drugs for type 2 diabetes
Sivagnanam G · Journal of Pharmacology and Pharmacotherapeutics
- The enema of your enemy is your friend
· Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026